Product Code: GVR-4-68040-121-9
Wound Contact Layer Dressing Market Growth & Trends:
The global wound contact layer dressing market size is anticipated to reach USD 964.19 Million by 2030, according to a new report by Grand View Research, Inc.. It is anticipated to expand at a CAGR of 12.8% during the forecast period. The primary driving factors for the market growth are the increasing prevalence of chronic diseases and the rising number of accidents that need advanced wound healing processes.
A wound contact layer dressing is a type of medical dressing designed to be in direct contact with a wound to protect it while allowing for proper wound healing and management. Wound contact dressings are usually designed not to adhere to the wound bed. This means they will not stick to the wound without hampering the healing process or causing further trauma when the dressing is removed. These dressings are typically low-lint or lint-free to minimize the risk of foreign particles getting into the wound and causing infection. These dressings are usually soft and flexible to conform to the shape of the wound, ensuring good contact while still allowing for movement and comfort. Wound contact layer dressings are made from various materials, including silicone, perforated films, and non-woven fabrics. The choice of material depends on factors such as the type of wound, exudate (fluid) levels, and desired moisture balance.
The prevalence of both chronic and acute wounds is rising, as is the demand for more advanced solutions for wound dressing. Additionally, the market is anticipated to profit from technical developments and a growing emphasis on creating novel products. The increasing incidence of chronic diseases such as diabetes, cancer, and other autoimmune diseases is anticipated to increase the incidence rate of chronic and acute wounds across the globe.
North America dominated the global market in 2022 and is projected to grow moderately during the forecast period. Increasing sports injuries, road accidents, and the presence of several key players in the region are anticipated to drive the market in North America. Asia Pacific market is projected to grow at the highest CAGR during the forecast period owing to the presence of developing countries such as China, India, and Japan is anticipated to boost the market growth in Asia Pacific region. This can be attributed to the presence of major market players and increasing prevalence of diabetes.
Wound Contact Layer Dressing Market Report Highlights:
- North America accounted for the largest share in 2022, owing to the presence of reimbursement policies and various awareness campaigns led by several organizations. The well-developed healthcare system and public awareness are major advantages for the healthcare system in North America.
- By product, non-antimicrobial segment dominated the global market while the antimicrobial segment is projected to grow at the fastest growth rate owing to its benefits of combating infections faster.
- By end-user, the hospital segment accounted for the largest market share owing to the growing incidence of chronic wounds, increased surgeries, and a rise in the aging population.
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.1.1. Product
- 1.1.2. End-use
- 1.1.3. Regional scope
- 1.1.4. Estimates and forecast timeline
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR's internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
- 1.3.5.1. Data for primary interviews in North America
- 1.3.5.2. Data for primary interviews in Europe
- 1.3.5.3. Data for primary interviews in Asia Pacific
- 1.3.5.4. Data for primary interviews in Latin America
- 1.3.5.5. Data for primary interviews in MEA
- 1.4. Information or Data Analysis
- 1.4.1. Data analysis models
- 1.5. Market Formulation & Validation
- 1.6. Model Details
- 1.6.1. Commodity flow analysis (Model 1)
- 1.6.1.1. Approach 1: Commodity flow approach
- 1.6.2. Volume price analysis (Model 2)
- 1.6.2.1. Approach 2: Volume price analysis
- 1.7. List of Secondary Sources
- 1.8. List of Primary Sources
- 1.9. Objectives
- 1.9.1. Objective 1
- 1.9.2. Objective 2
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Product outlook
- 2.2.2. End-use outlook
- 2.2.3. Regional outlook
- 2.3. Competitive Insights
Chapter 3. Wound Contact Layer Dressing Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Penetration & Growth Prospect Mapping
- 3.3. Market Dynamics
- 3.3.1. Market driver analysis
- 3.3.1.1. Increasing prevalence of chronic diseases impacting wound healing capabilities
- 3.3.1.2. Rising number of accidents
- 3.3.1.3. Increase in number of healthcare centers such as ASCs
- 3.3.2. Market restraint analysis
- 3.3.2.1. High cost of advanced wound care products
- 3.4. Wound Contact Layer Dressing Market Analysis Tools
- 3.4.1. Industry Analysis - Porter's
- 3.4.1.1. Supplier power
- 3.4.1.2. Buyer power
- 3.4.1.3. Substitution threat
- 3.4.1.4. Threat of new entrant
- 3.4.1.5. Competitive rivalry
- 3.4.2. PEST Analysis
- 3.4.2.1. Political landscape
- 3.4.2.2. Economic landscape
- 3.4.2.3. Social landscape
- 3.4.2.4. Technological landscape
Chapter 4. Wound Contact Layer Dressing Market: Product Estimates & Trend Analysis
- 4.1. Definitions and Scope
- 4.1.1. Antimicrobial
- 4.1.2. Non-antimicrobial
- 4.2. Product Market Share, 2022 & 2030
- 4.3. Segment Dashboard
- 4.4. Wound Contact Layer Dressing Market by Product Outlook
- 4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 4.5.1. Antimicrobial
- 4.5.1.1. Antimicrobial market estimates and forecast 2018 to 2030 (USD Million)
- 4.5.2. Non-antimicrobial
- 4.5.2.1. Non-antimicrobial market estimates and forecast 2018 to 2030 (USD Million)
Chapter 5. Wound Contact Layer Dressing Market: End-user Estimates & Trend Analysis
- 5.1. Definitions and Scope
- 5.1.1. Hospitals
- 5.1.2. Outpatient
- 5.1.3. Home Healthcare
- 5.1.4. Research & Manufacturing
- 5.2. End-user Market Share, 2022 & 2030
- 5.3. Segment Dashboard
- 5.4. Wound Contact Layer Dressing Market by End-user Outlook
- 5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 5.5.1. Hospitals
- 5.5.1.1. Hospitals market estimates and forecast 2018 to 2030, (USD Million)
- 5.5.2. Outpatient
- 5.5.2.1. Outpatient market estimates and forecast 2018 to 2030 (USD Million)
- 5.5.3. Home Healthcare
- 5.5.3.1. Outpatient market estimates and forecast 2018 to 2030 (USD Million)
- 5.5.4. Research & Manufacturing
- 5.5.4.1. Outpatient market estimates and forecast 2018 to 2030 (USD Million)
Chapter 6. Wound Contact Layer Dressing Market: Regional Estimates & Trend Analysis
- 6.1. Regional Market Share Analysis, 2022 & 2030
- 6.2. Regional Market Dashboard
- 6.3. Global Regional Market Snapshot
- 6.4. Regional Market Share and Leading Players, 2022
- 6.4.1. North America
- 6.4.2. Europe
- 6.4.3. Asia Pacific
- 6.4.4. Latin America
- 6.4.5. Middle East and Africa
- 6.5. Market Estimate & Forecasts and Trend Analysis, 2018 to 2030
- 6.6. North America
- 6.6.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
- 6.6.2. U.S.
- 6.6.2.1. Key country dynamics
- 6.6.2.2. Regulatory framework
- 6.6.2.3. Reimbursement scenario
- 6.6.2.4. U.S. market estimates and forecasts, 2018 - 2030
- 6.6.3. Canada
- 6.6.3.1. Key country dynamics
- 6.6.3.2. Regulatory framework
- 6.6.3.3. Reimbursement scenario
- 6.6.3.4. Canada market estimates and forecasts, 2018 - 2030
- 6.7. Europe
- 6.7.1. UK
- 6.7.1.1. Key country dynamics
- 6.7.1.2. Regulatory framework
- 6.7.1.3. Reimbursement scenario
- 6.7.1.4. UK market estimates and forecasts, 2018 - 2030
- 6.7.2. Germany
- 6.7.2.1. Key country dynamics
- 6.7.2.2. Regulatory framework
- 6.7.2.3. Reimbursement scenario
- 6.7.2.4. Germany market estimates and forecasts, 2018 - 2030
- 6.7.3. France
- 6.7.3.1. Key country dynamics
- 6.7.3.2. Regulatory framework
- 6.7.3.3. Reimbursement scenario
- 6.7.3.4. France market estimates and forecasts, 2018 - 2030
- 6.7.4. Italy
- 6.7.4.1. Key country dynamics
- 6.7.4.2. Regulatory framework
- 6.7.4.3. Reimbursement scenario
- 6.7.4.4. Italy market estimates and forecasts, 2018 - 2030
- 6.7.5. Spain
- 6.7.5.1. Key country dynamics
- 6.7.5.2. Regulatory framework
- 6.7.5.3. Reimbursement scenario
- 6.7.5.4. Spain market estimates and forecasts, 2018 - 2030
- 6.7.6. Denmark
- 6.7.6.1. Key country dynamics
- 6.7.6.2. Regulatory framework
- 6.7.6.3. Reimbursement scenario
- 6.7.6.4. Denmark market estimates and forecasts, 2018 - 2030
- 6.7.7. Sweden
- 6.7.7.1. Key country dynamics
- 6.7.7.2. Regulatory framework
- 6.7.7.3. Reimbursement scenario
- 6.7.7.4. Sweden market estimates and forecasts, 2018 - 2030
- 6.7.8. Norway
- 6.7.8.1. Key country dynamics
- 6.7.8.2. Regulatory framework
- 6.7.8.3. Reimbursement scenario
- 6.7.8.4. Norway market estimates and forecasts, 2018 - 2030
- 6.8. Asia Pacific
- 6.8.1. Japan
- 6.8.1.1. Key country dynamics
- 6.8.1.2. Regulatory framework
- 6.8.1.3. Reimbursement scenario
- 6.8.1.4. Japan market estimates and forecasts, 2018 - 2030
- 6.8.2. India
- 6.8.2.1. Key country dynamics
- 6.8.2.2. Regulatory framework
- 6.8.2.3. Reimbursement scenario
- 6.8.2.4. India market estimates and forecasts, 2018 - 2030
- 6.8.3. China
- 6.8.3.1. Key country dynamics
- 6.8.3.2. Regulatory framework
- 6.8.3.3. Reimbursement scenario
- 6.8.3.4. China market estimates and forecasts, 2018 - 2030
- 6.8.4. South Korea
- 6.8.4.1. Key country dynamics
- 6.8.4.2. Regulatory framework
- 6.8.4.3. Reimbursement scenario
- 6.8.4.4. South Korea market estimates and forecasts, 2018 - 2030
- 6.8.5. Australia
- 6.8.5.1. Key country dynamics
- 6.8.5.2. Regulatory framework
- 6.8.5.3. Reimbursement scenario
- 6.8.5.4. Australia market estimates and forecasts, 2018 - 2030
- 6.8.6. Thailand
- 6.8.6.1. Key country dynamics
- 6.8.6.2. Regulatory framework
- 6.8.6.3. Reimbursement scenario
- 6.8.6.4. Thailand market estimates and forecasts, 2018 - 2030
- 6.9. Latin America
- 6.9.1. Brazil
- 6.9.1.1. Key country dynamics
- 6.9.1.2. Regulatory framework
- 6.9.1.3. Reimbursement scenario
- 6.9.1.4. Brazil market estimates and forecasts, 2018 - 2030
- 6.9.2. Mexico
- 6.9.2.1. Key country dynamics
- 6.9.2.2. Regulatory framework
- 6.9.2.3. Reimbursement scenario
- 6.9.2.4. Mexico market estimates and forecasts, 2018 - 2030
- 6.9.3. Argentina
- 6.9.3.1. Key country dynamics
- 6.9.3.2. Regulatory framework
- 6.9.3.3. Reimbursement scenario
- 6.9.3.4. Argentina market estimates and forecasts, 2018 - 2030
- 6.10. MEA
- 6.10.1. South Africa
- 6.10.1.1. Key country dynamics
- 6.10.1.2. Regulatory framework
- 6.10.1.3. Reimbursement scenario
- 6.10.1.4. South Africa market estimates and forecasts, 2018 - 2030
- 6.10.2. Saudi Arabia
- 6.10.2.1. Key country dynamics
- 6.10.2.2. Regulatory framework
- 6.10.2.3. Reimbursement scenario
- 6.10.2.4. Saudi Arabia market estimates and forecasts, 2018 - 2030
- 6.10.3. UAE
- 6.10.3.1. Key country dynamics
- 6.10.3.2. Regulatory framework
- 6.10.3.3. Reimbursement scenario
- 6.10.3.4. UAE market estimates and forecasts, 2018 - 2030
- 6.10.4. Kuwait
- 6.10.4.1. Key country dynamics
- 6.10.4.2. Regulatory framework
- 6.10.4.3. Reimbursement scenario
- 6.10.4.4. Kuwait market estimates and forecasts, 2018 - 2030
Chapter 7. Competitive Landscape
- 7.1. Company/Competition Categorization
- 7.2. Vendor Landscape
- 7.2.1. List of key distributors and channel partners
- 7.2.2. Key customers
- 7.2.3. Key company market share analysis, 2022
- 7.2.4. Hollister Incorporated
- 7.2.4.1. Company overview
- 7.2.4.2. Financial performance
- 7.2.4.3. Product benchmarking
- 7.2.4.4. Strategic initiatives
- 7.2.5. 3M
- 7.2.5.1. Company overview
- 7.2.5.2. Financial performance
- 7.2.5.3. Product benchmarking
- 7.2.5.4. Strategic initiatives
- 7.2.6. Cardinal Health
- 7.2.6.1. Company overview
- 7.2.6.2. Financial performance
- 7.2.6.3. Product benchmarking
- 7.2.6.4. Strategic initiatives
- 7.2.7. Advanced Medical Solutions Limited
- 7.2.7.1. Company overview
- 7.2.7.2. Financial performance
- 7.2.7.3. Product benchmarking
- 7.2.7.4. Strategic initiatives
- 7.2.8. Avery Dennison Corporation
- 7.2.8.1. Company overview
- 7.2.8.2. Financial performance
- 7.2.8.3. Product benchmarking
- 7.2.8.4. Strategic initiatives
- 7.2.9. Elkem ASA
- 7.2.9.1. Company overview
- 7.2.9.2. Financial performance
- 7.2.9.3. Product benchmarking
- 7.2.9.4. Strategic initiatives
- 7.2.10. Paul Hartmann
- 7.2.10.1. Company overview
- 7.2.10.2. Financial performance
- 7.2.10.3. Product benchmarking
- 7.2.10.4. Strategic initiatives
- 7.2.11. BSN Medical
- 7.2.11.1. Company overview
- 7.2.11.2. Financial performance
- 7.2.11.3. Product benchmarking
- 7.2.11.4. Strategic initiatives
- 7.2.12. Smith + Nephew
- 7.2.12.1. Company overview
- 7.2.12.2. Financial performance
- 7.2.12.3. Product benchmarking
- 7.2.12.4. Strategic initiatives
- 7.2.13. Medline Industries
- 7.2.13.1. Company overview
- 7.2.13.2. Financial performance
- 7.2.13.3. Product benchmarking
- 7.2.13.4. Strategic initiatives
- 7.2.14. Molnlycke Health Care
- 7.2.14.1. Company overview
- 7.2.14.2. Financial performance
- 7.2.14.3. Product benchmarking
- 7.2.14.4. Strategic initiatives